Quote | 23andMe Holding Co. (NASDAQ:ME)
Last: | $0.425 |
---|---|
Change Percent: | 0.0% |
Open: | $0.4 |
Close: | $0.425 |
High: | $0.425 |
Low: | $0.3818 |
Volume: | 2,763,987 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | 23andMe Holding Co. (NASDAQ:ME)
SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in biomarker testing and risk prediction, today announced a strategic collaboration to pilot Nightingale Hea...
2024-06-16 15:58:28 ET A recent rash of cyberattacks on Corporate America has put cybersecurity back in the spotlight.... Read the full article on Seeking Alpha For further details see: SA Asks: What is the No. 1 cybersecurity threat facing companies today?
Message Board Posts | 23andMe Holding Co. (NASDAQ:ME)
Subject | By | Source | When |
---|---|---|---|
ME 23andMe Holding Company | mick | investorshub | 04/30/2023 11:08:22 PM |
Have 12k shares here now. The data here | Afterhoursearnings3 | investorshub | 04/19/2023 5:16:04 PM |
ME 23andMe Holding Company | mick | investorshub | 04/15/2023 3:50:12 PM |
ME 23andMe Holding Company | mick | investorshub | 02/27/2023 2:23:44 AM |
ME 23andMe Holding Company | mick | investorshub | 02/21/2023 11:50:45 PM |
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in biomarker testing and risk prediction, today announced a strategic collaboration to pilot Nightingale Hea...
SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, today released a new genetic Bipolar Disorder report (Powered by 23andMe Research) for 23andMe+ Premium members, informing them if they are at h...
2024-06-04 12:48:12 ET Genetic database builder 23andMe (NASDAQ: ME) stock slid 10% through 12:05 p.m. ET Tuesday. Curiously, though, the news that 23andMe reported today seemed generally of the "good" variety. The company announced a collaboration with the nonprofit Colorectal ...